St. Josefs-Hospital Wiesbaden

Statement of the AGG supported by DGGG and DGPGM on the S3 Guideline "Vaginal Birth at Term" (2021) Berger R, Maul H, Kehl S, Schiermeier S, Schlembach D, Kainer F, Abou-Dakn M Journal article, Editorial Caesarean Section. Guideline of the DGGG, OEGGG and SGGG (S3-Level, AWMF Registry No. 015/084, June 2020) (2021) Louwen F, Wagner U, Abou-Dakn M, Doetsch J, Lawrenz B, Ehm D, Surbek D, et al. Journal article, Review article Role and benefits of infectious diseases (ID) specialists in the COVID-19 pandemics (2021) Tscharntke L, Jung N, Rieg S, Spinner C, Hanses F, Borgmann S, Wille K, et al. Conference contribution ARD shows "GOTT": Open Letter from Palliative Medicine & Suicide Prevention to Ferdinand von Schirach (2021) Fiedler G, Drinkmann A, Hauth I, Lenz P, Letsch A, Lewitzka U, Maier BO, et al. Journal article, Editorial Update - Micronutrients in the Geriatrics (2018) Wirth R, Volkert D, Willschrei HP, Cuvelier IF, Schaefer R, Modreker MK, Gehrke I Journal article Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014) (2017) Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, et al. Journal article Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial (2016) Gluz O, Liedtke C, Huober J, Peyro-Saint-Paul H, Kates RE, Kreipe HH, Hartmann A, et al. Journal article Therapy of Cancer-Related Pain and Cancer Therapy-Related Pain (2015) Ostgathe C, Maier BO Authored book Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (2014) Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, et al. Journal article Daytime systolic ambulatory blood pressure with a two-step switch from candesartan to olmesartan monotherapy and the fixed-dose combination of olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-2) (2014) Bramlage P, Zemmrich C, Gansz A, Sturm CD, Fimmers R, Nadal J, Schmieder R, et al. Journal article